Pacritinib and Triptorelin: Interaction Details
- Pacritinib
- Vonjo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pacritinib and Triptorelin interaction:
Triptorelin
We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →
What Happens When You Take Pacritinib With Triptorelin
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Pacritinib should not be given together with any drug known to prolong the . Using other QT-prolonging drugs at the same time may add to the QTc-prolonging effect of pacritinib and raise the risk of cardiac .
Pacritinib should also be avoided in patients whose baseline QTc exceeds 480 msec. Pacritinib should be held if the lengthens beyond 500 msec or rises by more than 60 msec from baseline.
When QTc returns to 480 msec or less, or to baseline, within 1 week, pacritinib can be resumed at the same dose. When resolution takes longer than 1 week, pacritinib should be resumed at a lower dose. If cannot be avoided, should be corrected before and throughout pacritinib treatment, and QTc prolongation should be managed with interruption of pacritinib and electrolyte management.1
The Pacritinib and Triptorelin Interaction, Explained
Both of these medicines can affect your heart's electrical rhythm. Pacritinib (Vonjo) can lengthen a heart timing measure called the . Triptorelin, a hormone-lowering medicine, may do this too. Taking both could add up and raise the chance of a dangerous irregular heartbeat. This concern is mostly based on how the drugs are expected to work, not on proven cases.
Don't stop or change anything on your own. Your care team can manage this by checking your heart tracing () and your potassium levels, and by adjusting your treatment if needed. Tell them right away about fainting, dizziness, or a racing or fluttering heartbeat.
() between pacritinib and triptorelin (GnRH , androgen deprivation associated with QT prolongation). Evidence is theoretical; onset unspecified; severity rated major. Neither effect is a PK change, so no exposure shift is expected.
- Labeling advises avoiding pacritinib with QT-prolonging drugs and avoiding it if baseline is above 480 msec.
- If QTc exceeds 500 msec or rises more than 60 msec from baseline, hold pacritinib. Restart at the same dose if QTc recovers to 480 msec or less (or baseline) within 1 week; otherwise restart at a reduced dose.
- If is unavoidable, correct before and during therapy, monitor and electrolytes, and manage with interruption and electrolyte correction.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pacritinib and Triptorelin Interact
The likely mechanism
How to Manage the Pacritinib and Triptorelin Interaction
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may weigh whether this combination is needed and, if it is, may monitor you more closely.
- They may check your heart tracing () before and during treatment.
- They may check and correct low potassium.
- If your QTc rises too high, pacritinib may be paused and then restarted at the same or a reduced dose, individualized by your team.
Contact your pharmacist or doctor about any new fainting, palpitations, or dizziness, and before starting any new medicine.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pacritinib or Triptorelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Pacritinib and Triptorelin: Common Questions
How serious is the Pacritinib and Triptorelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Pacritinib and Triptorelin interaction managed?
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may weigh whether this combination is needed and, if it is, may monitor you more closely. They may check your heart tracing () before and during treatment. They may check and correct low potassium. If your QTc rises too high, pacritinib may be paused and then restarted at the same or a reduced do… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Pacritinib and Triptorelin Interaction
Ask in your own words about taking Pacritinib and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Other Serious Interactions of Pacritinib and Triptorelin
Also serious with Pacritinib
- AdagrasibContraindicated
- CarbamazepineContraindicated
- CeritinibContraindicated
- ClarithromycinContraindicated
Also serious with Triptorelin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Pacritinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.